Inventor · disambiguated record
Christopher James Bungard
Also filed as: BUNGARD CHRISTOPHER J · BUNGARD CHRISTOPHER JAMES
16 granted patents·5 pending applications·23 citations·filing 2007–2024
88Inventor score
Files withMERCK SHARP & DOHME10MERCK SHARP & DOHME LLC7BEAULIEU CHRISTIAN1BUNGARD CHRISTOPHER J1BUNGARD CHRISTOPHER JAMES1
Top patents by PatentIndex Score
21 records- 0191US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0281US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 0380US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0476US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 0576US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 0672US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 0772US9315475B2HIV protease inhibitorsBEAULIEU CHRISTIAN·Filed 2013·Granted Apr 19, 2016·5 cites·23 claims
- 0870US10138255B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 27, 2018·1 cites·19 claims
- 0970US9840478B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·13 claims
- 1070US2023312528A12-oxo-imidazolidine-4-carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1167US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 1264US9737545B2HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 1362US11802122B22-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 31, 2023·0 cites·46 claims
- 1458US2025066323A1Inhibitors of human respiratory syncytial virus and metapneumovirusMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1553US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 1652US2023365531A1Inhibitors of human respiratory syncytial virus and metapneumo virusMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1744US12344595B22-amino-n-phenyl-nicotinamides as NAV1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·15 claims
- 1844US9834526B2HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 5, 2017·0 cites·20 claims
- 1939US8119681B22-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligandsBUNGARD CHRISTOPHER J·Filed 2007·Granted Feb 21, 2012·0 cites·17 claims
- 2036US9994587B2HIV protease inhibitorsMERCK CANADA INC·Filed 2015·Granted Jun 12, 2018·0 cites·17 claims
- 2133US2012214847A12-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDSBUNGARD CHRISTOPHER JAMES·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher James Bungard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →